Evidence map›Paper›PMID 27405931›Full record

ArticleBMC cancer2016

Silibinin induces mitochondrial NOX4-mediated endoplasmic reticulum stress response and its subsequent apoptosis.

Sang-Hun Kim, Kwang-Youn Kim, Sun-Nyoung Yu, Young-Kyo Seo, Sung-Sik Chun, Hak-Sun Yu, Soon-Cheol Ahn

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Silybin induces endothelium-dependent vasodilation via TRPV4 channels in mouse mesenteric arteries.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Mitochondrial Dysfunction Secondary to Endoplasmic Reticulum Stress in Acute Myocardial Ischemic Injury in Rats.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  10. Review
  11. Observational
  12. NOX2-Derived Reactive Oxygen Species in Cancer.Oxidative medicine and cellular longevity · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sang-Hun KimDepartment of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan, 626-870, Republic of Korea.
Kwang-Youn KimSchool of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan, 689-798, Republic of Korea.
Sun-Nyoung YuDepartment of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan, 626-870, Republic of Korea.
Young-Kyo SeoSchool of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan, 689-798, Republic of Korea.
Sung-Sik ChunDepartment of Food Science, International University of Korea, Jinju, 660-759, Republic of Korea.
Hak-Sun YuImmunoregulatory Therapeutics Group in Brain Busan 21 Project, Pusan National University, Yangsan, 626-870, Republic of Korea.
Soon-Cheol AhnDepartment of Microbiology & Immunology, Pusan National University School of Medicine, Yangsan, 626-870, Republic of Korea. ahnsc@pusan.ac.kr.
Pusan National University · KRUlsan National Institute of Science and Technology · KRInternational University of Korea · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSilibinin, a biologically active compound of milk thistle, has chemopreventive effects on cancer cell lines. Recently it was reported that silibinin inhibited tumor growth through activation of the apoptotic signaling pathway. Although various evidences showed multiple signaling pathways of silibinin in apoptosis, there were no reports to address the clear mechanism of ROS-mediated pathway in prostate cancer PC-3 cells. Several studies suggested that reactive oxygen species (ROS) play an important role in various signaling cascades, but the primary source of ROS was currently unclear.

methodsThe effect of silibinin was investigated on cell growth of prostate cell lines by MTT assay. We examined whether silibinin induced apoptosis through production of ROS using flow cytometry. Expression of apoptosis-, endoplasmic reticulum (ER)-related protein and gene were determined by western blotting and RT-PCR, respectively.

resultsResults showed that silibinin triggered mitochondrial ROS production through NOX4 expression and finally led to induce apoptosis. In addition, mitochondrial ROS caused ER stress through disruption of Ca(2+) homeostasis. Co-treatment of ROS inhibitor reduced the silibinin-induced apoptosis through the inhibition of NOX4 expression, resulting in reduction of both Ca(2+) level and ER stress response.

conclusionsTaken together, silibinin induced mitochondrial ROS-dependent apoptosis through NOX4, which is associated with disruption of Ca(2+) homeostasis and ER stress response. Therefore, the regulation of NOX4, mitochondrial ROS producer, could be a potential target for the treatment of prostate cancer.

Indexed as

Antineoplastic AgentsApoptosisCell Line, TumorCell ProliferationCell SurvivalEndoplasmic ReticulumEndoplasmic Reticulum StressHumansMaleMitochondriaNADPH Oxidase 4NADPH OxidasesProstatic NeoplasmsReactive Oxygen SpeciesSignal TransductionSilybinAntineoplastic AgentsNADPH Oxidase 4NADPH OxidasesNOX4 protein, humanReactive Oxygen SpeciesSilybinSilymarinApoptosisCa2+Endoplasmic reticulum stressNOXReactive oxygen speciesSilibinin

Identifiers

PMID27405931
PMCPMC4942927
OpenAlexW2473259496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.